Inside the research

Penumbra, Inc.

PEN Research profile · latest available data

Price overview

$318.89

▼ -0.83 (-0.3%)

52w hi$359.40
52w lo$225.54
Vol228.10K
As of25 Sep 2026

The Verdict

Hold

Our score -0.28

Short-0.31
Medium-0.22
Long-0.35

computed 2026-09-27

Key fundamentals

Penumbra, Inc.

Healthcare · Medical Devices

Market cap$12.56B
Enterprise value$12.11B
Trailing P/E78.16x
Forward P/E52.00x
EV / EBITDA59.30x
P / S (ttm)8.35x
Profit margin10.7%
Return on equity11.4%
Revenue growth+14.9%
Earnings growth-23.5%
Debt / equity13.90

Layer Breakdown

LayerRawContribution
Fundamental+0.04
Sector+0.08
Technical-0.25
Earnings+0.00
Sentiment+0.00

macro × 1.00 · 2026-09-27

Business overview

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX, BENCHMARK, BMX, DDC, Access25; MIDWAY, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization device, aspiration tubing, aspiration pump, and other components and accessories under the Penumbra RED, SENDit, JET, ACE, BMX, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that include the Penumbra Coil 400, for the treatment of aneurysms and other complex lesions, detachable coils of neurovascular lesions under the Penumbra SMART COIL, SwiftSET, and Penumbra SwiftPAC Coil brands; and POD400 and PAC400 brands. In addition, it provides peripheral embolization products, such as Ruby Embolization Platform, which consists of detachable coils for peripheral applications; Ruby LP and XL Embolization Platform; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; Packing Coil LP; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers neurosurgical tools comprising the Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. It sells its products through direct sales organizations and distributors. The company was incorporated in 2004 and is based in Alameda, California.

United States · www.penumbrainc.com

Risk Metrics

Beta vs SPX0.55
Corr SPX0.27
Annual vol32.4%
Annual ret+29.7%
Sharpe0.92
Max DD-25.8%

Window: 504 trading days (504 obs)

Analyst Coverage

Mean PT$363.36
High / Low$374.00 / $326.00
Median$374.00
Analysts14
Strong Buy2
Buy2
Hold13
Sell0
Strong Sell0

Recent rating actions

2026-05-07Evercore ISI Group→ Outperform
2026-05-07Citigroup→ Neutral
2026-02-26Evercore ISI Group→ Outperform
2026-01-20RBC Capital→ Sector Perform
2026-01-20Canaccord Genuity→ Hold
2026-01-16Truist Securities→ Hold

Material Events

DateEvent8-K
2026-07-30Earnings Release, Exhibitsread
2026-06-22Shareholder Voteread
2026-05-07Shareholder Voteread
2026-05-06Earnings Release, Exhibitsread
2026-02-25Earnings Release, Exhibitsread
2026-01-15Material Agreement, Earnings Release…read
2025-11-05Earnings Release, Exhibitsread
2025-08-27Officer / Director Change, Reg FD Disclosure…read
2025-07-29Earnings Release, Exhibitsread
2025-05-30Bylaws Amendment, Shareholder Vote…read
2025-04-23Earnings Release, Exhibitsread
2025-02-21Officer / Director Change, Reg FD Disclosure…read

Insider Trades

DateInsiderRoleActionSharesValue
2026-05-19Elsesser AdamCEOGift77.00K—
2026-04-02Grewal HarpreetSell100$32.82K
2026-03-15Narayan ShruthiPresidentWithheld for tax117$39.33K
2026-03-15Roberts JohannaEVP, Gen. Counsel & SecreWithheld for tax186$62.53K
2026-03-15Yuen MaggieChief Financial OfficerWithheld for tax186$62.53K
2026-03-15Shiu LambertChief Accounting OfficerWithheld for tax150$50.43K
2026-03-02Yuen MaggieChief Financial OfficerSell2.43K$832.47K
2026-02-13Grewal HarpreetGrant589—
2026-02-13Bose AraniGrant589—
2026-02-13Leeds JanetGrant589—

Flow & Concentration

Insider 180d net-$32.82K
Insider buys / sells0 / 1
Insider biasNeutral
13F holders9
Top-5 share97.0%
HHI2,342 (moderate)

Top Holders

HolderValueShares
State Street Corp$392.56M1.24M
Millennium Management$299.21M947.61K
Capital Research / Capital World$222.23M703.82K
Citadel Advisors$158.40M501.66K
Fidelity / FMR LLC$66.62M211.00K
Renaissance Technologies$25.10M79.50K
AQR Capital Management$10.03M31.78K
Bridgewater Associates$498.88K1.58K
T. Rowe Price Group$14.09K44.62K

As of 2026-06-30

SEC Filings

DateFormDoc
2026-07-308-Kview
2026-07-3010-Qview
2026-06-228-Kview
2026-05-214view
2026-05-078-Kview
2026-05-068-Kview
2026-05-0610-Qview
2026-04-29DEFA14Aview
2026-04-29ARSview
2026-04-29DEF 14Aview
2026-04-064view
2026-03-174view
2026-03-174view
2026-03-174view
2026-03-174view

The Long Run

FY 2015–2025 · 11 years

LineLatestCAGRTrend
Revenue$1.06B+42.1%
Gross profit$755.00M+24.7%
Operating income$73.55M+50.6%
Net income$177.69M+61.6%
Cash from ops$97.33M+38.2%

Indices

S&P MidCap 400

Recent Sessions

DateOpenHighLowCloseVol
Sep 25$319.28$319.61$318.17$318.89228.10K
Sep 24$318.98$320.27$318.33$319.72483.00K
Sep 23$319.46$320.26$318.40$319.44410.60K
Sep 22$319.80$319.80$318.49$319.39797.90K
Sep 21$317.38$318.78$316.77$318.78292.90K

Understand the score. Research layers are inputs to a model, and the available data has limits.

Read the methodology →